Connection

HELEN HESLOP to Killer Cells, Lymphokine-Activated

This is a "connection" page, showing publications HELEN HESLOP has written about Killer Cells, Lymphokine-Activated.
  1. Possible mechanism of selective killing of myeloid leukemic blast cells by lymphokine-activated killer cells. Blood. 1991 May 01; 77(9):1996-2001.
    View in: PubMed
    Score: 0.022
  2. Effects of recombinant interleukin-2 administration on cytotoxic function following high-dose chemo-radiotherapy for hematological malignancy. Blood. 1989 Nov 15; 74(7):2335-42.
    View in: PubMed
    Score: 0.020
  3. Malignant plasma cells are sensitive to LAK cell lysis: pre-clinical and clinical studies of interleukin 2 in the treatment of multiple myeloma. Br J Haematol. 1990 Aug; 75(4):499-505.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.